ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,567.19
0.00%
US Tech 100
19,864.00
0.09%
Dow Jones
39,375.87
0.00%
Brent Oil
85.725
-0.90%
Bitcoin
57,234.86
2.49%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Morphic Holding Inc (MORF) Quote

Morphic Holding Inc

Morphic Holding Inc (MORF)

NASDAQ
31.84
0.01
(0.03%)
Closed July 05 4:00PM
Delayed by 15 minutes
55.80
23.96
( 75.25% )
Pre Market: 9:11AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
55.80
Bid
55.81
Ask
55.83
Volume
9,343,895
0.00 Day's Range 0.00
19.345 52 Week Range 62.08
Market Cap
1.595B
Previous Close
31.84
Open
-
Last Trade
99
@
55.8292
Last Trade Time
09:12:08
Financial Volume
-
VWAP
-
Average Volume (3m)
502,089
Shares Outstanding
50,093,588
Dividend Yield
-
PE Ratio
-10.49
Earnings Per Share (EPS)
-3.04
Revenue
521k
Net Profit
-152.1M

About Morphic Holding Inc

Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, inc... Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
ww.morphictx.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Morphic Holding Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MORF. The last closing price for Morphic was $31.84. Over the last year, Morphic shares have traded in a share price range of $ 19.345 to $ 62.08.

Morphic currently has 50,093,588 shares outstanding. The market capitalization of Morphic is $1.59 billion. Morphic has a price to earnings ratio (PE ratio) of -10.49.

MORF Latest News

More News

Form SC14D9C - Written communication relating to third party tender offer

2 hours ago
Edgar (US Regulatory)

Form 8-K - Current report

2 hours ago
Edgar (US Regulatory)

Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease

Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease PR Newswire INDIANAPOLIS and WALTHAM, Mass., July 8, 2024 Acquisition to expand Lilly's immunology...

3 hours ago
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

June 05 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 05 2024
Edgar (US Regulatory)

Form 8-K - Current report

June 05 2024
Edgar (US Regulatory)

Morphic to Participate in Jefferies Global Healthcare Conference

WALTHAM, Mass., May 31, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious...

May 31 2024
GlobeNewswire Inc.

Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells

-α4β7 Inhibition Rapidly Increases the Rolling Velocity and Flux of B Cells in Gut-associated Lymphoid Tissues- -Impact of Potent and Selective Small Molecule Inhibitor Comparable to Monoclonal...

May 21 2024
GlobeNewswire Inc.

Morphic to Participate in RBC Capital Markets Global Healthcare Conference

WALTHAM, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious...

May 09 2024
GlobeNewswire Inc.

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

- Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- -Appointed Dr. Simon Cooper as Chief Medical Officer- -Anticipate dosing first patient in GARNET...

April 25 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
121.7263.732394366234.0834.5931.0127052431.94696915CS
425.6885.258964143430.1234.5925.2560311729.77797814CS
1227.2295.241427571728.5834.5925.2550208929.73700146CS
2628.78106.5136935627.0241.4725.2550984931.78203214CS
52-1.81-3.14181565757.6162.0819.34565235730.90679499CS
156-0.06-0.10741138560755.8668.7519.2343134635.52072717CS
26032.03134.74968447623.77939.931374137.43864472CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SVMHSRIVARU Holding Ltd
$ 0.339
(113.34%)
29.07M
IVPInspire Veterinary Partners Inc
$ 3.02
(102.68%)
16.26M
MORFMorphic Holding Inc
$ 55.80
(75.25%)
9.25M
ZAPPZapp Electric Vehicles Group Ltd
$ 6.75
(65.85%)
11.95M
SHPWShapeways Holdings Inc
$ 0.3202
(52.48%)
12.21M
HLVXHilleVax Inc
$ 1.9593
(-86.06%)
5.65M
CLEUChina Liberal Education Holdings Ltd
$ 1.43
(-34.40%)
979.61k
BENFBeneficient
$ 3.91
(-19.21%)
398.48k
QLGNQualigen Therapeutics Inc
$ 0.23505
(-16.05%)
1.64M
KOSSKoss Corporation
$ 11.32
(-15.21%)
1.1M
MAXNMaxeon Solar Technologies Ltd
$ 0.289
(20.42%)
98.32M
SVMHSRIVARU Holding Ltd
$ 0.339
(113.34%)
29.07M
CEROCERo Therapeutics Holdings Inc
$ 0.3328
(30.97%)
24.37M
IVPInspire Veterinary Partners Inc
$ 3.02
(102.68%)
16.26M
KAKineta Inc
$ 0.73
(20.30%)
12.34M

MORF Discussion

View Posts
Invest-in-America Invest-in-America 1 hour ago
MORF: However, its PRICE will remain all day long at that circa $57-per-share offer price from Lilly. (SORRY for my initial excitement here.)
👍️0
Invest-in-America Invest-in-America 2 hours ago
MORF: Buy-out!!
👍️0
bikaver bikaver 9 months ago
MORF.....20.50 to 24.00 in 3 days
👍️0
bikaver bikaver 9 months ago
MORF.....In today @ 20.50 after hours.
👍️0
R9CC R9CC 1 year ago
Lawyers are looking into the company prior to the annual meeting:
https://thebrios.com/morphic-holding-inc-investors-investigation/
👍️0

Your Recent History

NASDAQ
MORF
Morphic
BIT
P1OYL9
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved